Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted oesophageal administration of ZN-α2-glycoproteins (ZAG), methods and formulations thereof

Targeted oesophageal administration of ZN-α2-glycoproteins (ZAG), methods and formulations thereof

US Patent 10172917 · Granted Jan 8, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glycoproteins having lipid mobilizing properties and therapeutic uses thereof2018
Glycoproteins having lipid mobilizing properties and therapeutic uses thereof2018
Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating di2014
Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate2013
Methods for the treatment of muscle loss2012
HMB uses thereof2012
Antibodies to proteolysis inducing factor (PIF) receptor and methods of use ther2012
Antiproliferative agents2010
Glycoproteins having lipid mobilising properties and therapeutic applications th2009
Antiproliferative agents2006
Glycoproteins having lipid mobilizing properties and therapeutic applications th2005
Antiproliferative agents2005